3 Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancer
Blagden, S., Hamilton, A., Mileshkin, L., Hall, M., Meniawy, T., Wong, S., Anandra, S., Buck, M., McAleer, D., Reedy, B.A., Noble, R.B., Smith, D.A., Morris, S.R., Gabra, H.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70129-7
Date:
November, 2014
File:
PDF, 53 KB
english, 2014